Bryan R. Haugen

42.5k total citations · 9 hit papers
159 papers, 27.7k citations indexed

About

Bryan R. Haugen is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Bryan R. Haugen has authored 159 papers receiving a total of 27.7k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Endocrinology, Diabetes and Metabolism, 36 papers in Molecular Biology and 32 papers in Oncology. Recurrent topics in Bryan R. Haugen's work include Thyroid Cancer Diagnosis and Treatment (94 papers), Thyroid Disorders and Treatments (35 papers) and Thyroid and Parathyroid Surgery (21 papers). Bryan R. Haugen is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (94 papers), Thyroid Disorders and Treatments (35 papers) and Thyroid and Parathyroid Surgery (21 papers). Bryan R. Haugen collaborates with scholars based in United States, Canada and Italy. Bryan R. Haugen's co-authors include Steven I. Sherman, Susan J. Mandel, David L. Steward, Martin Schlumberger, R. Michael Tuttle, Furio Pacini, Gerard M. Doherty, Erik K. Alexander, David S. Cooper and Yuri E. Nikiforov and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Bryan R. Haugen

152 papers receiving 27.0k citations

Hit Papers

2015 American Thyroid Ass... 2006 2026 2012 2019 2015 2009 2006 2012 2009 2.5k 5.0k 7.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryan R. Haugen United States 53 23.6k 12.4k 3.9k 3.8k 3.7k 159 27.7k
R. Michael Tuttle United States 76 30.7k 1.3× 17.0k 1.4× 3.1k 0.8× 5.3k 1.4× 4.6k 1.2× 326 34.1k
Furio Pacini Italy 74 30.5k 1.3× 15.4k 1.2× 3.9k 1.0× 5.0k 1.3× 4.5k 1.2× 258 35.2k
Susan J. Mandel United States 50 24.6k 1.0× 13.0k 1.0× 2.2k 0.6× 3.7k 1.0× 2.9k 0.8× 99 28.0k
Rossella Elisei Italy 72 18.4k 0.8× 6.2k 0.5× 4.5k 1.2× 2.2k 0.6× 3.4k 0.9× 370 23.3k
Ernest L. Mazzaferri United States 59 18.2k 0.8× 12.0k 1.0× 2.1k 0.5× 2.9k 0.8× 2.6k 0.7× 303 23.1k
Henning Dralle Germany 73 15.9k 0.7× 13.8k 1.1× 4.0k 1.0× 1.4k 0.4× 2.6k 0.7× 585 26.8k
Leonard Wartofsky United States 54 17.1k 0.7× 7.4k 0.6× 2.4k 0.6× 2.8k 0.7× 2.1k 0.6× 282 20.6k
Keith C. Bible United States 39 11.5k 0.5× 6.1k 0.5× 2.4k 0.6× 2.1k 0.6× 1.7k 0.5× 94 15.0k
Electron Kebebew United States 69 9.8k 0.4× 7.7k 0.6× 3.8k 1.0× 862 0.2× 2.4k 0.6× 378 19.1k
Martin Schlumberger France 93 39.8k 1.7× 19.9k 1.6× 6.3k 1.6× 7.1k 1.9× 5.9k 1.6× 387 50.2k

Countries citing papers authored by Bryan R. Haugen

Since Specialization
Citations

This map shows the geographic impact of Bryan R. Haugen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan R. Haugen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan R. Haugen more than expected).

Fields of papers citing papers by Bryan R. Haugen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan R. Haugen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan R. Haugen. The network helps show where Bryan R. Haugen may publish in the future.

Co-authorship network of co-authors of Bryan R. Haugen

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan R. Haugen. A scholar is included among the top collaborators of Bryan R. Haugen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan R. Haugen. Bryan R. Haugen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barrio, Martin, Nikita Pozdeyev, Christopher D. Raeburn, et al.. (2024). Pre-operative thyroglobulin measurement for thyroid cancer risk of recurrence and response to therapy. The American Journal of Surgery. 238. 115818–115818.
2.
Barrio, Martin, et al.. (2023). Computer-Assisted Levothyroxine Dose Selection for the Treatment of Postoperative Hypothyroidism. Thyroid. 33(5). 547–555. 6 indexed citations
3.
Mehta, Vikas, David Liao, Louise Davies, et al.. (2021). What's in a Name? A Cost-Effectiveness Analysis of the Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features' Nomenclature Revision. Thyroid. 32(4). 421–428. 4 indexed citations
4.
Bales, Elise S., Sharon B. Sams, David J. Orlicky, et al.. (2021). Lenvatinib Plus Anti-PD-1 Combination Therapy for Advanced Cancers: Defining Mechanisms of Resistance in an Inducible Transgenic Model of Thyroid Cancer. Thyroid. 32(2). 153–163. 14 indexed citations
5.
Figge, James, William E. Gooding, David L. Steward, et al.. (2021). Do Ultrasound Patterns and Clinical Parameters Inform the Probability of Thyroid Cancer Predicted by Molecular Testing in Nodules with Indeterminate Cytology?. Thyroid. 31(11). 1673–1682. 20 indexed citations
6.
Wahdan-Alaswad, Reema S., Susan M. Edgerton, Hyunmin Kim, et al.. (2020). Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor–Positive Breast Cancers. Clinical Cancer Research. 27(2). 585–597. 10 indexed citations
7.
Pozdeyev, Nikita, Timothy A. Erickson, Lian Zhang, et al.. (2020). Comprehensive Immune Profiling of Medullary Thyroid Cancer. Thyroid. 30(9). 1263–1279. 39 indexed citations
8.
Sawka, Anna M., Erik K. Alexander, Antônio C. Bianco, et al.. (2020). Challenges in Developing Recommendations Based on Low-Quality Evidence in Thyroid Guidelines. Thyroid. 31(1). 3–7. 2 indexed citations
9.
Landa, Iñigo, Nikita Pozdeyev, Christopher Korch, et al.. (2019). Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies. Clinical Cancer Research. 25(10). 3141–3151. 130 indexed citations
10.
Schweppe, Rebecca E., Nikita Pozdeyev, Laura A. Pike, et al.. (2019). Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers. Molecular Cancer Research. 17(5). 1036–1048. 12 indexed citations
11.
Sawka, Anna M., Anna R. Gagliardi, Megan R. Haymart, et al.. (2019). A Survey of American Thyroid Association Members Regarding the 2015 Adult Thyroid Nodule and Differentiated Thyroid Cancer Clinical Practice Guidelines. Thyroid. 30(1). 25–33. 11 indexed citations
12.
Pozdeyev, Nikita, Laurie M. Gay, Ethan Sokol, et al.. (2018). Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers. Clinical Cancer Research. 24(13). 3059–3068. 374 indexed citations breakdown →
13.
Patel, Nayana, Kimberly E. Lind, Toshimasa Clark, et al.. (2018). Clinical Validation of a Predictive Model for the Presence of Cervical Lymph Node Metastasis in Papillary Thyroid Cancer. American Journal of Neuroradiology. 39(4). 756–761. 4 indexed citations
14.
Haugen, Bryan R., Erik K. Alexander, Keith C. Bible, et al.. (2015). 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 26(1). 1–133. 9985 indexed citations breakdown →
15.
Serracino, Hilary S., Christopher D. Raeburn, Robert C. McIntyre, et al.. (2015). PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunology Research. 3(6). 620–630. 74 indexed citations
16.
McLeod, Donald S.A., David S. Cooper, Paul W. Ladenson, et al.. (2013). Prognosis of Differentiated Thyroid Cancer in Relation to Serum Thyrotropin and Thyroglobulin Antibody Status at Time of Diagnosis. Thyroid. 24(1). 35–42. 103 indexed citations
17.
Chan, Christine M., Jing Xia, Laura A. Pike, et al.. (2012). Targeted Inhibition of Src Kinase with Dasatinib Blocks Thyroid Cancer Growth and Metastasis. Clinical Cancer Research. 18(13). 3580–3591. 91 indexed citations
18.
Cooper, David S., Gerard M. Doherty, Bryan R. Haugen, et al.. (2009). Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 19(11). 1167–1214. 5125 indexed citations breakdown →
19.
Netea‐Maier, Romana T., Stephen W. Hunsucker, Brigiet M. Hoevenaars, et al.. (2008). Discovery and Validation of Protein Abundance Differences between Follicular Thyroid Neoplasms. Cancer Research. 68(5). 1572–1580. 46 indexed citations
20.
Schweppe, Rebecca E., Joshua Klopper, Christopher Korch, et al.. (2008). Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification. The Journal of Clinical Endocrinology & Metabolism. 93(11). 4331–4341. 490 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026